Scholars Central

Short communicationPublished 29 Oct 2024

Exploring the Role of Targeted Therapies in Treating Bone Metastases

Authors: Jonathan Dangl

Radiotherapy, National Oncology Center, Baku, Azerbaijan

Cervical Cancer: Open Access

Volume 9 · Issue 5 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Bone metastases, where cancer cells spread to the bone from a primary tumor, present significant challenges in oncology, including pain, fractures, and a reduced quality of life. Traditional treatments often involve systemic therapies, radiation, and surgery, but targeted therapies have emerged as a transformative approach in managing bone metastases. This article explores the role of targeted therapies in treating bone metastases, focusing on their mechanisms, types, benefits, and challenges. Targeted therapies, including bisphosphonates, denosumab, and radiopharmaceuticals, offer precision in addressing bone resorption and tumor growth, aiming to reduce skeletalrelated events and enhance patient outcomes. The article also discusses ongoing research and future directions in this evolving field.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCervical Cancer: Open Access
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Jonathan Dangl”